BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 15494526)

  • 1. Urokinase induces basophil chemotaxis through a urokinase receptor epitope that is an endogenous ligand for formyl peptide receptor-like 1 and -like 2.
    de Paulis A; Montuori N; Prevete N; Fiorentino I; Rossi FW; Visconte V; Rossi G; Marone G; Ragno P
    J Immunol; 2004 Nov; 173(9):5739-48. PubMed ID: 15494526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 envelope gp41 peptides promote migration of human Fc epsilon RI+ cells and inhibit IL-13 synthesis through interaction with formyl peptide receptors.
    de Paulis A; Florio G; Prevete N; Triggiani M; Fiorentino I; Genovese A; Marone G
    J Immunol; 2002 Oct; 169(8):4559-67. PubMed ID: 12370393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R.
    Resnati M; Pallavicini I; Wang JM; Oppenheim J; Serhan CN; Romano M; Blasi F
    Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1359-64. PubMed ID: 11818541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basophils infiltrate human gastric mucosa at sites of Helicobacter pylori infection, and exhibit chemotaxis in response to H. pylori-derived peptide Hp(2-20).
    de Paulis A; Prevete N; Fiorentino I; Walls AF; Curto M; Petraroli A; Castaldo V; Ceppa P; Fiocca R; Marone G
    J Immunol; 2004 Jun; 172(12):7734-43. PubMed ID: 15187157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of the N-formyl Peptide receptors in scleroderma fibroblasts fosters the switch to myofibroblasts.
    Rossi FW; Napolitano F; Pesapane A; Mascolo M; Staibano S; Matucci-Cerinic M; Guiducci S; Ragno P; di Spigna G; Postiglione L; Marone G; Montuori N; de Paulis A
    J Immunol; 2015 Jun; 194(11):5161-73. PubMed ID: 25917089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The synthetic peptide Trp-Lys-Tyr-Met-Val-Met-NH2 specifically activates neutrophils through FPRL1/lipoxin A4 receptors and is an agonist for the orphan monocyte-expressed chemoattractant receptor FPRL2.
    Christophe T; Karlsson A; Dugave C; Rabiet MJ; Boulay F; Dahlgren C
    J Biol Chem; 2001 Jun; 276(24):21585-93. PubMed ID: 11285256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Urokinase/Urokinase Receptor System in Mast Cells: Effects of its Functional Interaction with fMLF Receptors.
    Rossi FW; Prevete N; Rivellese F; Napolitano F; Montuori N; Postiglione L; Selleri C; de Paulis A
    Transl Med UniSa; 2016 Nov; 15():34-41. PubMed ID: 27896225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The urokinase receptor is required for human monocyte chemotaxis in vitro.
    Gyetko MR; Todd RF; Wilkinson CC; Sitrin RG
    J Clin Invest; 1994 Apr; 93(4):1380-7. PubMed ID: 8163642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A urokinase-sensitive region of the human urokinase receptor is responsible for its chemotactic activity.
    Fazioli F; Resnati M; Sidenius N; Higashimoto Y; Appella E; Blasi F
    EMBO J; 1997 Dec; 16(24):7279-86. PubMed ID: 9405357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclo19,31[D-Cys19]-uPA19-31 is a potent competitive antagonist of the interaction of urokinase-type plasminogen activator with its receptor (CD87).
    Magdolen V; Bürgle M; de Prada NA; Schmiedeberg N; Riemer C; Schroeck F; Kellermann J; Degitz K; Wilhelm OG; Schmitt M; Kessler H
    Biol Chem; 2001 Aug; 382(8):1197-205. PubMed ID: 11592401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cleavage of the urokinase receptor regulates its multiple functions.
    Montuori N; Carriero MV; Salzano S; Rossi G; Ragno P
    J Biol Chem; 2002 Dec; 277(49):46932-9. PubMed ID: 12297505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilization of two seven-transmembrane, G protein-coupled receptors, formyl peptide receptor-like 1 and formyl peptide receptor, by the synthetic hexapeptide WKYMVm for human phagocyte activation.
    Le Y; Gong W; Li B; Dunlop NM; Shen W; Su SB; Ye RD; Wang JM
    J Immunol; 1999 Dec; 163(12):6777-84. PubMed ID: 10586077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysophosphatidylcholine induces urokinase-type plasminogen activator and its receptor in human macrophages partly through redox-sensitive pathway.
    Oka H; Kugiyama K; Doi H; Matsumura T; Shibata H; Miles LA; Sugiyama S; Yasue H
    Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):244-50. PubMed ID: 10634825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical role of integrin alpha 5 beta 1 in urokinase (uPA)/urokinase receptor (uPAR, CD87) signaling.
    Tarui T; Andronicos N; Czekay RP; Mazar AP; Bdeir K; Parry GC; Kuo A; Loskutoff DJ; Cines DB; Takada Y
    J Biol Chem; 2003 Aug; 278(32):29863-72. PubMed ID: 12754207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urokinase plasminogen activator and urokinase plasminogen activator receptor mediate human stem cell tropism to malignant solid tumors.
    Gutova M; Najbauer J; Frank RT; Kendall SE; Gevorgyan A; Metz MZ; Guevorkian M; Edmiston M; Zhao D; Glackin CA; Kim SU; Aboody KS
    Stem Cells; 2008 Jun; 26(6):1406-13. PubMed ID: 18403751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect.
    Resnati M; Guttinger M; Valcamonica S; Sidenius N; Blasi F; Fazioli F
    EMBO J; 1996 Apr; 15(7):1572-82. PubMed ID: 8612581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. uPAR regulates pericellular proteolysis through a mechanism involving integrins and fMLF-receptors.
    Montuori N; Cosimato V; Rinaldi L; Rea VE; Alfano D; Ragno P
    Thromb Haemost; 2013 Feb; 109(2):309-18. PubMed ID: 23238745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urokinase plasminogen activator amino-terminal peptides inhibit development of the rat ventral prostate.
    Elfman F; Bok R; Conn M; Shuman M; Cunha G
    Differentiation; 2001 Dec; 69(2-3):108-20. PubMed ID: 11798065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amino-terminal fragment of urokinase inhibits tumor cell invasion in vitro and in vivo: respective contribution of the urokinase plasminogen activator receptor-dependent or -independent pathway.
    Li H; Soria C; Griscelli F; Opolon P; Soria J; Yeh P; Legrand C; Vannier JP; Belin D; Perricaudet M; Lu H
    Hum Gene Ther; 2005 Oct; 16(10):1157-67. PubMed ID: 16218777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urokinase-mediated posttranscriptional regulation of urokinase-receptor expression in non small cell lung carcinoma.
    Montuori N; Mattiello A; Mancini A; Taglialatela P; Caputi M; Rossi G; Ragno P
    Int J Cancer; 2003 Jun; 105(3):353-60. PubMed ID: 12704669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.